 ASI Industries Ltd Q2FY26 profit at Rs. 81.30 lakhs
ASI Industries Ltd Q2FY26 profit at Rs. 81.30 lakhs Jubilant Pharmova Ltd consolidated Q2FY26 net profit rises to Rs. 120.3 crores
Jubilant Pharmova Ltd consolidated Q2FY26 net profit rises to Rs. 120.3 crores Bharat Electronics Ltd Q2 FY2025-26 consolidated profit at Rs. 1287.77 crores
Bharat Electronics Ltd Q2 FY2025-26 consolidated profit at Rs. 1287.77 crores ACC Ltd consolidated Q2 FY2026 PAT zooms to Rs. 1119.23 crores
ACC Ltd consolidated Q2 FY2026 PAT zooms to Rs. 1119.23 crores Intellect Design Arena Ltd consolidated Q2FY26 net profit up at Rs. 102.27 crores
Intellect Design Arena Ltd consolidated Q2FY26 net profit up at Rs. 102.27 crores 
              COLGATE 3QFY11: Below est; Toothpaste volume up 13%; PAT down 37% due to high costs; Cutting est 13-18%; Neutral
Net sales grew 13.8% to Rs5.6b (est Rs5.7b) on back of toothpaste volume growth of 13% (est 13.5%). Overall volumes grew 12%
Gross margin expanded 290bp to 60.1%, not comparable YoY due to merger of erstwhile subsidiaries (contract manufacturers).
Ad-spend grew 60.2% to Rs1.2b and expanded 630bp to 21.6% (as a % to sales). Staff cost increased 28.8% (110bp).
EBITDA margin, consequently contracted 760bp to 16.1% (est 25.5%). EBITDA de-grew 23% YoY to Rs931m
Adj PAT de-growth was aggravated due to higher tax rate (27.4% in 3QFY11 vs 13.6% in 3QFY10) resulting in Adj PAT decline of 37% to Rs663m (est Rs1.1b).
We estimate 13% PAT CAGR over FY11-13E. On revised estimates the stock trades at 25.7x FY12E and 22.2x FY13E. We believe sustained margin pressure and lower growth rates can de-rate the stock in the coming quarters. Maintain Neutral with a target price of Rs742 (20x FY13E EPS).